StreetAlpha.app
Home › Stocks › STLN

Starling Oncology, Inc. (STLN)

Healthcare
$3.00
▼ −5.66%
LAST CLOSE · NOV 20

The Oncology Institute provides outpatient cancer care, specialty pharmacy and clinical trial services from Cerritos, California. It last closed at $3.00 on Nov 20, down 5.66% on the day. The next earnings report for STLN is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, STLN reported EPS of -$0.13 on revenue of $169.8M, with revenue up 24.3% from a year ago. Over its last 8 reports the stock moved an average of 20.0% the session after earnings. Over the last 12 months STLN insiders bought $2.9M of stock on the open market and sold $14.0M, according to SEC Form 4 filings.

AI Auto Pilots
Is STLN in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold STLN.

Key Stats

Last 12 months
Results
Revenue
$620.4M
+34.6% vs a year ago
Net income
−$35.5M
−5.7% margin
EPS (diluted)
−$0.28
Free cash flow
$18.8M
3.0% margin
Valuation
Market cap
$306.0M
102.0M shares
P/E
–
No P/E while losing money
Price to sales
0.5
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$36.9M
At Sep 30
Debt
$72.5M
At Sep 30
Shareholder equity
−$37.4M
Shares outstanding
102.0M
At Nov 3
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $203.0M$203.0MFY2021FY2022: $252.5M$252.5MFY2022FY2023: $324.2M$324.2MFY2023FY2024: $393.4M$393.4MFY2024FY2025: $502.7M$502.7MFY2025

From STLN's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 6). Last 12 months adds up the four latest quarters.

Next report
Jan 11
Estimated date · Time not announced
Reported EPS
-$0.13
Quarter ended Sep 2026
Year ago EPS
-$0.14
Same quarter last year
Revenue
$169.8M
+24.3% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.15Dec '24Mar 2025: -$0.21Mar '25Jun 2025: -$0.15Jun '25Sep 2025: -$0.14Sep '25Dec 2025: -$0.05Dec '25Mar 2026: -$0.02Mar '26Jun 2026: -$0.08Jun '26Sep 2026: -$0.13Sep '26Latest -$0.13
Revenue by quarter
Dec 2024: $100.3MDec '24Mar 2025: $104.4MMar '25Jun 2025: $119.8MJun '25Sep 2025: $136.6MSep '25Dec 2025: $142.0MDec '25Mar 2026: $147.4MMar '26Jun 2026: $161.3MJun '26Sep 2026: $169.8MSep '26Latest $169.8M
How STLN moved after its last 8 reports
Average move the session after a report ±20.0%
Nov 5, 2026After the close−46.0%
Aug 6, 2026After the close+28.5%
May 7, 2026After the close−1.7%
Mar 12, 2026After the close+8.4%
Jan 12, 2026Time not announced−7.9%
Nov 13, 2025After the close+28.9%
Aug 13, 2025After the close−10.5%
May 14, 2025After the close+28.3%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on STLNStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on STLN
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on STLN

Technical Analysis

STLN · as of the Nov 20 close · updated each morning
Turning down, oversold

The stock is 64% below its 20 day and 98% below its 50 day average. It is 60% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 26), oversold. The nearest support is the Pivot S1 at $2.89, and the nearest resistance the Pivot at $3.08.

Short trendBearish
Long trendNeutral
MomentumWeak
StretchOversold
VolatilityHigh, 17.1%/day
Key levels
$7.1352 week high+137.7%
$5.9350 day average+97.7%
$5.87100 day average+95.7%
$4.9320 day average+64.3%
$4.89Swing high (Jun 1)+63.0%
$4.80200 day average+60.0%
$3.19Pivot R1+6.3%
$3.08Pivot+2.7%
$3.00Last close
$2.89Pivot S1−3.7%
$2.3252 week low−22.7%
Indicators
RSI (14)26.45Oversold below 30Oversold
MACD-0.89Below its signal lineBearish
Stochastic1.3Near the bottom of its rangeOversold
ADX (14)37.2Trending down
Williams %R-99.3Oversold below −80, overbought above −20Oversold
CCI (20)-92.8Oversold below −100, overbought above 100Neutral
Rate of change−17.1%Change over 10 sessionsBearish
ATR (14)$0.51Typical daily range, 17.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for STLN

What happened before

See how STLN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow STLN usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How STLN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for STLNHow many large options trades hit STLN, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

STLN Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲73 buying vs 47 selling
  • ▲Held by funds +2.9 pts
  • ▲Funds holding +11
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding131120+9.2%
In funds' top 1032+50.0%
Held by funds42.2%39.3%+2.9 pts
New / increased26 / 4727 / 51−6.4%
Reduced / sold out32 / 1525 / 220.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See STLN institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

STLN Insider Trading

All filings →
Insider trading · 12 months
Insiders are net sellers
Bought$2.9M14 buys · 1 insider
Sold$14.0M7 sales · 5 insiders
18% of the selling was under pre-arranged trading plans.
2025-12 sold $50K2026-01 sold $8792026-03 bought $1.9M2026-04 bought $62K2026-04 sold $335K2026-05 bought $279K2026-06 bought $147K2026-06 sold $126K2026-07 bought $183K2026-07 sold $150K2026-08 bought $78K2026-08 sold $1.9M2026-11 bought $176K2026-11 sold $11.4MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 9Jorey Chernett10% ownerBuy48,294$3.65$176K
Nov 6Jorey Chernett10% ownerSale2,851,061$3.99$11.4M
Aug 21Brad HivelyDirectorSale plan298,853$6.51$1.9M
Aug 14Jorey Chernett10% ownerBuy12,000$6.54$78K
Jul 21Jorey Chernett10% ownerBuy18,000$5.27$95K
Jul 14Yale PodnosChief Medical OfficerSale plan23,452$6.41$150K
Every insider buy and sale for STLN over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See STLN insider trades →

From SEC Form 4 filings by STLN's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether STLN is in one of them and how their past STLN trades turned out.

STLN in the AI portfolios
Loading…

STLN News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered STLN in an article yet. Here's the latest on the wider market.

STLN in the news

STLN Congress Trades

All congress trades →
Trades, 12 months
12
Buys
0
0%
Sells
12
100%
People
1
Last filed Oct 26
Who traded STLN · since 2026
Latest 5 filings of 12
Richard BlumenthalSell (partial)
$1K – $15KTraded Sep 23, 2026Filed Oct 26, 2026
Richard BlumenthalSell (partial)
$1K – $15KTraded Sep 23, 2026Filed Oct 26, 2026
Richard BlumenthalSell (partial)
$15K – $50KTraded Sep 22, 2026Filed Oct 26, 2026
Richard BlumenthalSell (partial)
$15K – $50KTraded Sep 22, 2026Filed Oct 26, 2026
Richard BlumenthalSell (partial)
$15K – $50KTraded Sep 22, 2026Filed Oct 26, 2026
PersonTypeAmountTradedFiledDelay
Richard BlumenthalD · CTSell (partial)$1K – $15KSep 23, 2026Oct 26, 202633 d
Richard BlumenthalD · CTSell (partial)$1K – $15KSep 23, 2026Oct 26, 202633 d
Richard BlumenthalD · CTSell (partial)$15K – $50KSep 22, 2026Oct 26, 202634 d
Richard BlumenthalD · CTSell (partial)$15K – $50KSep 22, 2026Oct 26, 202634 d
Richard BlumenthalD · CTSell (partial)$15K – $50KSep 22, 2026Oct 26, 202634 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Starling Oncology

The Oncology Institute is a cancer care company based in Cerritos, California. It provides outpatient cancer treatment, including medical oncology, radiation oncology, infusion therapy and specialty pharmacy services, through clinics in five states. Its patients are mostly referred by other doctors and health plans. It is paid either for each service it delivers or by health plans under contracts that set a fixed amount per patient. It also runs clinical trial services for drug companies.

Headquarters
Cerritos, CA